IMR Press / FBL / Special Issues / 1326790608014442497

Advances in metabolic syndrome and diabetes mellitus

Submission deadline: 31 December 2011
Special Issue Editor
  • Undurti N. Das, MD
    CEO/CSO of UND Life Sciences, 2221 NW 5th St, Battle Ground, WA 98604, USA; Chief Medical Officer and Chairman of the Scientific Advisory Board, ASHA Nutrition, CA, USA
    Interests: Cancer; Diabetes mellitus; Lupus; Coronary heart disease; Atherosclerosis; Sepsis; Radiation protection
    Special Issues and Topics in IMR Press journals
Cardiovascular System
Cell Biology
Endocrine System
Immune System
Inflammatory Responses
Molecular Biology
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (2 Papers)
Back to top